prof. dr. J.A. (Johan) den Boer

Professor of Psychopharmacology and Neuroscience

prof. dr. J.A. (Johan) den Boer
E-mail:
j.a.den.boer umcg.nl

Research

  1. 2020
  2. 2019
  3. van Buel, E. M., Meddens, M. J. M., Arnoldussen, E. A., van den Heuvel, E. R., Bohlmeijer, W. C., den Boer, J. A., ... Klein, H. C. (2019). Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers. Journal of Psychosomatic Research, 125, [109796]. https://doi.org/10.1016/j.jpsychores.2019.109796
  4. 2018
  5. 2016
  6. 2015
  7. Dobos, N., de Vries, E. F. J., Kema, I. P., Patas, K., Prins, M., Nijholt, I. M., ... Eisel, U. L. M. (2015). The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. In G. S. Smith (Ed.), Handbook of Depression in Alzheimer's Disease (Vol. 4, pp. 163-173). (Advances in Alzheimer's Disease; Vol. 4). IOS Press. https://doi.org/10.3233/978-1-61499-542-5-163
  8. 2014
  9. Bosker, F., Doorduin, J., Jongsma, M., Visser, A., Udo De Haes, J., Cremers, T., ... Westerink, B. (2014). Pharmacological Interventions That Have the Potential to Alter Neurotransmitter Levels in the Human Brain. In R. A. J. O. Dierckx, A. Otte, E. F. J. de Vries, A. van Waarde, & J. A. den Boer (Eds.), PET and SPECT in Psychiatry (pp. 45-63). Springer. https://doi.org/10.1007/978-3-642-40384-2_3
  10. Visser, A., van Waarde, A., Bosker, F., den Boer, J., & Dierckx, R. (2014). The Serotonergic System as a Target for Positron Emission Tomography Ligands: Applications in Affective Disorders. In B. P. Guiard, & E. Dremencov (Eds.), Neurobiology of Mood Disorders (pp. 34-57). Bussum: Bentham Science Publishers. https://doi.org/10.2174/97816080546711140101
  11. 2013
  12. 2012
  13. Konopka, K-H., Harbers, M., Houghton, A., Kortekaas, R., van Vliet, A., Timmerman, W., ... van Wijhe, M. (2012). Somatosensory Profiles but Not Numbers of Somatosensory Abnormalities of Neuropathic Pain Patients Correspond with Neuropathic Pain Grading. PLoS ONE, 7(8), [e43526]. https://doi.org/10.1371/journal.pone.0043526
  14. Naudé, P. J. W., Nyakas, C., Eiden, L. E., Ait-Ali, D., Heide, R. V. D., Engelborghs, S., ... Eisel, U. L. M. (2012). Lipocalin 2: Novel component of proinflammatory signaling in Alzheimer's disease. The FASEB Journal, 26(7), 2811-2823. https://doi.org/10.1096/fj.11-202457
  15. Konopka, K-H., Harbers, M., Houghton, A., Kortekaas, R., van Vliet, A., Timmerman, W., ... van Wijhe, M. (2012). Bilateral Sensory Abnormalities in Patients with Unilateral Neuropathic Pain; A Quantitative Sensory Testing (QST) Study. PLoS ONE, 7(5), [e37524]. https://doi.org/10.1371/journal.pone.0037524
  16. 2011
  17. Dagyte, G., Crescente, I., Postema, F., Seguin, L., Gabriel, C., Mocaer, E., ... Dagytė, G. (2011). Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behavioral Brain Research, 218(1), 121-128. https://doi.org/10.1016/j.bbr.2010.11.045
  18. Delucchi, K. L., Katerberg, H., Stewart, S. E., Denys, D. A. J. P., Lochner, C., Stack, D. E., ... Mathews, C. A. (2011). Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder. Comprehensive Psychiatry, 52(3), 334-341. https://doi.org/10.1016/j.comppsych.2010.06.007
  19. 2010
  20. Katerberg, H., Delucchi, K. L., Stewart, S. E., Lochner, C., Denys, D. A. J. P., Stack, D. E., ... Cath, D. C. (2010). Symptom Dimensions in OCD: Item-Level Factor Analysis and Heritability Estimates. Behavior Genetics, 40(4), 505-517. https://doi.org/10.1007/s10519-010-9339-z
  21. Baldwin, D. S., Allgulander, C., Altamura, A. C., Angst, J., Bandelow, B., den Boer, J., ... Zohar, J. (2010). Manifesto for a European Anxiety Disorders Research Network. European Neuropsychopharmacology, 20(6), 426-432. https://doi.org/10.1016/j.euroneuro.2010.02.015
Previous 1 2 3 4 Next

ID: 49998